← Eichor
Study identifier: NCT05090267 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study

Condition: Cognition · Gut Microbiome  ·  Sponsor: University of Florida

PhaseNA
Planned participants80
Who can joinAll sexes, 35 Years to 70 Years
Healthy volunteersNo

About this study

This project uses a hybrid trial design to evaluate two biomedical interventions targeting the gut-brain axis. One intervention is portable Transcutaneous Vagus Nerve Stimulator, tVNS, that is hypothesized to stimulate the autonomic nervous system, resulting in decreased inflammation and improved cognition. The second intervention is a probiotic supplement intended to replace gut bacteria that are associated with dysbiosis in persons with HIV and alcohol consumption.

This description comes directly from the study's public registry record.

Talk to the study team

Emily Carter  ·  352-294-5837  ·  em.carter@phhp.ufl.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of MiamiCoral Gables, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05090267